Back to Search
ANJENI KESWANI, M.D.
M.D.
Allergy & Immunology (Internal Medicine) Physician
NPI: 1558527515Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
125052802(IL)
Allergy & Immunology (Internal Medicine) PhysicianPrimary
Internal Medicine — Allergy & Immunology
Code: 207RA0201X
MD0444010(DC)
Research & Publications (7)
The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects.
PMID 19342499·J Cardiovasc Pharmacol Ther·2009
4-observational
Arginase promotes neointima formation in rat injured carotid arteries.
PMID 19164802·Arterioscler Thromb Vasc Biol·2009
7-preclinical
Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family.
PMID 18422776·Br J Haematol·2008
8-other
alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer.
PMID 17968656·Breast Cancer Res Treat·2008
8-other
Butylated hydroxyanisole stimulates heme oxygenase-1 gene expression and inhibits neointima formation in rat arteries.
PMID 17320844·Cardiovasc Res·2007
7-preclinical
Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries.
PMID 16309565·Cell Mol Biol (Noisy-le-grand)·2005
7-preclinical
Single perivascular delivery of mitomycin C stimulates p21 expression and inhibits neointima formation in rat arteries.
PMID 16141400·Arterioscler Thromb Vasc Biol·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 251 E HURON ST
CHICAGO, IL 60611 - Phone
- (312) 926-2000
Quick Facts
- NPI
- 1558527515
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 7
Are you this provider?
Claim Your Profile